USP Comments submitted to FDA on Continuous Manufacturing for Docket No. FDA-2017-N-2697 for “Submission of Proposed Recommendations for Industry on Developing Continuous Manufacturing of Solid Dosage Drug Products in Pharmaceutical Manufacturing. Comments submitted 2017.
